Examinant per Autoria "Barratt, Jonathan"
Mostrant 1 - 1 de 1
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy(Elsevier, 2023) Barratt, Jonathan; Lafayette, Richard; Kristensen, Jens; Stone, Andrew; Cattran, Daniel; Floege, Jürgen; Tesar, Vladimir; Trimarchi, Hernán; Zhang, Hong; Eren, Necmi; Paliege, Alexander; Rovin, Brad H.; NefIgArd Trial Investigators